Search results

Sample environments, Data analysis, SpICE and SICS

Ongoing media statements relating to nuclear medicine production.

The first National Graduate Innovation Forum will be held in November to connect PhD students with representatives from four of Australia’s leading industries to apply scientific thinking to current real-world challenges. 

On this page you will find useful information about applying for a position at ANSTO and some tips on how you can prepare for an interview. 

See details of previously published customer updates from our Health products team. 

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

Latest information on the scheduled supply of our nuclear medicine production.

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.

The Japanese experience with leading-edge radiation treatment for cancer shows tremndous success

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.